Gastric Inhibitory Polypeptide: the neglected incretin revisited
- 11 April 2002
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 107 (1-3) , 1-13
- https://doi.org/10.1016/s0167-0115(02)00039-3
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Lack of Effect of Exogenous or Endogenous Gastric Inhibitory Polypeptide on the Elimination Rate of Intralipid® in ManActa Medica Scandinavica, 2009
- Regulated hepatic insulin gene therapy of STZ-diabetic ratsGene Therapy, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999
- Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in manDigestive Diseases and Sciences, 1993
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Absence of hepatic extraction of gastric inhibitory polypeptide in conscious dogsDigestive Diseases and Sciences, 1987
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987
- Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)FEBS Letters, 1981
- Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intoleranceEuropean Journal of Clinical Investigation, 1979
- The incretin concept todayDiabetologia, 1979